{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:07:34Z","timestamp":1792008454747,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008474","name":"New Jersey Commission on Brain Injury Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008474","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118796","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:16:37Z","timestamp":1763763397000},"page":"118796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cyclic nucleotide phosphodiesterase 1 and cognitive impairment: Mechanistic insights and therapeutic implications"],"prefix":"10.1016","volume":"193","author":[{"given":"Hailiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Brzostek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhutao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baomin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5479-7922","authenticated-orcid":false,"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118796_bib1","article-title":"H: reinvigorating the public health response to dementia.","volume":"6","author":"Lancet Public","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.biopha.2025.118796_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118796_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.biopha.2025.118796_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-023-00640-5","article-title":"Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer's disease","volume":"18","author":"Inoue","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2025.118796_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.add9993","article-title":"Blots on a field?","volume":"377","author":"Piller","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118796_bib6","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","article-title":"Mechanisms of sex differences in Alzheimer's disease","volume":"112","author":"Lopez-Lee","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118796_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer's disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118796_bib8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118796_bib9","article-title":"Astrocytic cAMP modulates memory via synaptic plasticity","volume":"118","author":"Zhou","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118796_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neubiorev.2020.02.004","article-title":"Role of cyclic nucleotides and their downstream signaling cascades in memory function: being at the right time at the right spot","volume":"113","author":"Argyrousi","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2025.118796_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/nan.12203","article-title":"Decreased levels of guanosine 3\u2032, 5\u2032-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease","volume":"41","author":"Ugarte","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118796_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-3-319-58811-7_13","article-title":"Phosphodiesterase 1: a unique drug target for degenerative diseases and cognitive dysfunction","volume":"17","author":"Wennogle","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118796_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0006-291X(70)90747-3","article-title":"Cyclic 3\u2032,5\u2032-nucleotide phosphodiesterase","volume":"38","author":"Cheung","year":"1970","journal-title":"Demonstr. Act. Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.118796_bib14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/0006-291X(70)90199-3","article-title":"Calcium dependent phosphodiesterase activity and its activating factor (PAF) from brain studies on cyclic 3\u2032,5\u2032-nucleotide phosphodiesterase (3)","volume":"41","author":"Kakiuchi","year":"1970","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.118796_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2025.118796_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1523\/JNEUROSCI.14-03-01251.1994","article-title":"Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation","volume":"14","author":"Polli","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118796_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1523\/JNEUROSCI.14-03-00973.1994","article-title":"Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain","volume":"14","author":"Yan","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118796_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0898-6568(01)00207-8","article-title":"Isolation and differential tissue distribution of two human cDNAs encoding PDE1 splice variants","volume":"14","author":"Fidock","year":"2002","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2025.118796_bib19","doi-asserted-by":"crossref","first-page":"25699","DOI":"10.1074\/jbc.271.41.25699","article-title":"The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner","volume":"271","author":"Yan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107858","article-title":"Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities","volume":"226","author":"Samidurai","year":"2021","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118796_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118796_bib22","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1016\/S0021-9258(17)47292-9","article-title":"Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies","volume":"259","author":"Sharma","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/bi00324a020","article-title":"Characterization of a Ca2+-calmodulin-stimulated cyclic GMP phosphodiesterase from bovine brain","volume":"24","author":"Shenolikar","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2025.118796_bib24","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.1016\/S0021-9258(19)37619-7","article-title":"Testis-specific calmodulin-dependent phosphodiesterase. A distinct high affinity cAMP isoenzyme immunologically related to brain calmodulin-dependent cGMP phosphodiesterase","volume":"263","author":"Rossi","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib25","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1016\/S0021-9258(18)81703-3","article-title":"Regulation of Ca2+\/calmodulin-dependent cyclic nucleotide phosphodiesterase by the autophosphorylated form of Ca2+\/calmodulin-dependent protein kinase II","volume":"264","author":"Hashimoto","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib26","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0021-9258(17)36094-5","article-title":"Calmodulin and Ca2+-dependent phosphorylation and dephosphorylation of 63-kDa subunit-containing bovine brain calmodulin-stimulated cyclic nucleotide phosphodiesterase isozyme","volume":"261","author":"Sharma","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib27","doi-asserted-by":"crossref","first-page":"14160","DOI":"10.1016\/S0021-9258(18)66997-2","article-title":"Purification and characterization of bovine lung calmodulin-dependent cyclic nucleotide phosphodiesterase. An enzyme containing calmodulin as a subunit","volume":"261","author":"Sharma","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0076-6879(88)59053-5","article-title":"Purification of calmodulin-stimulated cyclic nucleotide phosphodiesterase by monoclonal antibody affinity chromatography","volume":"159","author":"Hansen","year":"1988","journal-title":"Methods Enzym."},{"key":"10.1016\/j.biopha.2025.118796_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0167-4781(00)00293-1","article-title":"Human Ca2+\/calmodulin-dependent phosphodiesterase PDE1A: novel splice variants, their specific expression, genomic organization, and chromosomal localization","volume":"1517","author":"Michibata","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.118796_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0021-9258(18)54200-9","article-title":"Molecular cloning of a cDNA encoding the \"61-kDa\" calmodulin-stimulated cyclic nucleotide phosphodiesterase. Tissue-specific expression of structurally related isoforms","volume":"268","author":"Sonnenburg","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib31","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1021\/bi00246a010","article-title":"Sequence comparison of the 63-, 61-, and 59-kDa calmodulin-dependent cyclic nucleotide phosphodiesterases","volume":"30","author":"Novack","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2025.118796_bib32","doi-asserted-by":"crossref","first-page":"30989","DOI":"10.1074\/jbc.270.52.30989","article-title":"Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases","volume":"270","author":"Sonnenburg","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib33","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1021\/bi00246a009","article-title":"Evidence for domain organization within the 61-kDa calmodulin-dependent cyclic nucleotide phosphodiesterase from bovine brain","volume":"30","author":"Charbonneau","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2025.118796_bib34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1074\/jbc.271.2.796","article-title":"Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3\u2032,5\u2032-cyclic nucleotide phosphodiesterases","volume":"271","author":"Loughney","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib35","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1073\/pnas.89.22.11079","article-title":"Molecular cloning of DNA encoding a calmodulin-dependent phosphodiesterase enriched in striatum","volume":"89","author":"Polli","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118796_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0898-6568(97)00046-6","article-title":"Identification and characterisation of a human calmodulin-stimulated phosphodiesterase PDE1B1","volume":"9","author":"Yu","year":"1997","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2025.118796_bib37","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1073\/pnas.92.21.9677","article-title":"Molecular cloning and characterization of a calmodulin-dependent phosphodiesterase enriched in olfactory sensory neurons","volume":"92","author":"Yan","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118796_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1070677","article-title":"The role of phosphodiesterase-1 and its natural product inhibitors in Alzheimer's disease: a review","volume":"13","author":"Ahmad","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118796_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnmol.2019.00021","article-title":"Phosphodiesterase 1b (PDE1B) regulates spatial and contextual memory in hippocampus","volume":"12","author":"McQuown","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2025.118796_bib40","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1523\/JNEUROSCI.22-12-05188.2002","article-title":"Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning","volume":"22","author":"Reed","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118796_bib41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0024-3205(84)90242-X","article-title":"Phosphorylation and activation of calmodulin-sensitive cyclic nucleotide phosphodiesterase by a brain Ca2+, calmodulin-dependent protein kinase","volume":"35","author":"Fukunaga","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118796_bib42","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1471-4159.1985.tb08781.x","article-title":"Is Ca2+-calmodulin-dependent protein phosphorylation in rat brain modulated by carboxylmethylation?","volume":"44","author":"Billingsley","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118796_bib43","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/odi.12275","article-title":"Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets","volume":"21","author":"Ahmad","year":"2015","journal-title":"Oral. Dis."},{"key":"10.1016\/j.biopha.2025.118796_bib44","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1073\/pnas.82.9.2603","article-title":"Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase","volume":"82","author":"Sharma","year":"1985","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118796_bib45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1471-4159.2002.00903.x","article-title":"Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation","volume":"81","author":"Ang","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118796_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresbull.2018.03.016","article-title":"A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits","volume":"140","author":"Aghsami","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2025.118796_bib47","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00213-023-06361-3","article-title":"Phosphodiesterase inhibitors in psychiatric disorders","volume":"240","author":"Sadeghi","year":"2023","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.biopha.2025.118796_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1101\/lm.723708","article-title":"Constitutive activation of the G-protein subunit Galphas within forebrain neurons causes PKA-dependent alterations in fear conditioning and cortical Arc mRNA expression","volume":"15","author":"Kelly","year":"2008","journal-title":"Learn Mem."},{"key":"10.1016\/j.biopha.2025.118796_bib49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biotechadv.2016.12.005","article-title":"Natural products against Alzheimer's disease: pharmaco-therapeutics and biotechnological interventions","volume":"35","author":"Dey","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2025.118796_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2009.08.027","article-title":"Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor","volume":"620","author":"Deshmukh","year":"2009","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118796_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112512","article-title":"The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (a\u03b2) peptide","volume":"383","author":"Shekarian","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2025.118796_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-021-00506-8","article-title":"The role of inflammasomes in vascular cognitive impairment","volume":"17","author":"Poh","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2025.118796_bib53","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jpsychires.2006.02.008","article-title":"Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia","volume":"41","author":"Zuliani","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.biopha.2025.118796_bib54","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.neurobiolaging.2015.05.013","article-title":"Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy","volume":"36","author":"Schmitz","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2025.118796_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103449","article-title":"Inhibition of calcium-calmodulin-dependent phosphodiesterase (PDE1) suppresses inflammatory responses","volume":"102","author":"O'Brien","year":"2020","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.biopha.2025.118796_bib56","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.apsb.2022.09.023","article-title":"Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: Suppression of neuroinflammation by blocking NF-\u03baB transcription regulation and activating cAMP\/CREB axis","volume":"13","author":"Zhou","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2025.118796_bib57","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1128\/MCB.20.24.9356-9363.2000","article-title":"Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3b","volume":"20","author":"Li","year":"2000","journal-title":"Eta. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118796_bib58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2007.03.033","article-title":"Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation","volume":"418","author":"Chen","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2025.118796_bib59","doi-asserted-by":"crossref","first-page":"G727","DOI":"10.1152\/ajpgi.00410.2001","article-title":"cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release","volume":"283","author":"Webster","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2025.118796_bib60","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1042\/CS20150605","article-title":"Cyclic nucleotide phosphodiesterase 1 and vascular aging","volume":"129","author":"Yan","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2025.118796_bib61","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1042\/CS20140753","article-title":"Phosphodiesterase 1 regulation is a key mechanism in vascular aging","volume":"129","author":"Bautista Ni\u00f1o","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2025.118796_bib62","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1111\/j.1742-4658.2010.07908.x","article-title":"Ca2+\/calmodulin-stimulated PDE1 regulates the beta-catenin\/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells","volume":"277","author":"Jeon","year":"2010","journal-title":"Febs J."},{"key":"10.1016\/j.biopha.2025.118796_bib63","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1567202612666150603130235","article-title":"Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia","volume":"12","author":"Gupta","year":"2015","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.biopha.2025.118796_bib64","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.109.198515","article-title":"Role of Ca2+\/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy","volume":"105","author":"Miller","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118796_bib65","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/ATVBAHA.110.212621","article-title":"Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cells","volume":"31","author":"Cai","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2025.118796_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(01)01614-4","article-title":"cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation","volume":"436","author":"Prickaerts","year":"2002","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118796_bib67","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.106.144501","article-title":"cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology","volume":"100","author":"Zaccolo","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118796_bib68","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1021\/acs.jmedchem.5b01751","article-title":"Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib69","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.apsb.2022.09.023","article-title":"Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: suppression of neuroinflammation by blocking NF-kappaB transcription regulation and activating cAMP\/CREB axis","volume":"13","author":"Zhou","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2025.118796_bib70","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1248\/bpb.b15-00881","article-title":"Vinpocetine improves scopolamine induced learning and memory dysfunction in C57 BL\/6J mice","volume":"39","author":"Shang","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2025.118796_bib71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12868-023-00790-8","article-title":"Neuroprotective effects of vinpocetine, as a phosphodiesterase 1 inhibitor, on long-term potentiation in a rat model of Alzheimer's disease","volume":"24","author":"Shekarian","year":"2023","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.biopha.2025.118796_bib72","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1007\/s00213-016-4346-2","article-title":"Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats","volume":"233","author":"Snyder","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118796_bib73","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/bph.14350","article-title":"Targeting the dopamine D(1) receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance","volume":"175","author":"Pekcec","year":"2018","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118796_bib74","article-title":"Structural insights into PDE1 inhibition: binding mode of ITI-214 to PDE1B","volume":"213","author":"Nadur","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118796_bib75","article-title":"Structure of ITI-214, a PDE1 inhibitor in clinical trials","author":"Smith","year":"2017","journal-title":"ResearchGate"},{"key":"10.1016\/j.biopha.2025.118796_bib76","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/jpet.119.260869","article-title":"A novel phosphodiesterase 1 inhibitor DSR-141562 exhibits efficacies in animal models for positive, negative, and cognitive symptoms associated with schizophrenia","volume":"371","author":"Enomoto","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.118796_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108454","article-title":"Phosphodiesterase type 1 inhibition alters medial prefrontal cortical activity during goal-driven behaviour and partially reverses neurophysiological deficits in the rat phencyclidine model of schizophrenia","volume":"186","author":"Hayes","year":"2021","journal-title":"Neuropharmacology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:08:58Z","timestamp":1777014538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":77,"alternative-id":["S0753332225009904"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118796","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclic nucleotide phosphodiesterase 1 and cognitive impairment: Mechanistic insights and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118796"}}